- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 271/113 - 1,3,4-OxadiazolesHydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
Patent holdings for IPC class C07D 271/113
Total number of patents in this class: 290
10-year publication summary
|
26
|
26
|
30
|
22
|
18
|
18
|
18
|
30
|
18
|
5
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Cropscience AG | 1878 |
27 |
| King Faisal University | 930 |
16 |
| Bayer AG | 3470 |
10 |
| BASF SE | 21165 |
9 |
| Syngenta Crop Protection AG | 6577 |
7 |
| Cytokinetics, Inc. | 256 |
7 |
| Abbvie Inc. | 1837 |
6 |
| Calico Life Sciences LLC | 106 |
6 |
| Bayer Intellectual Property GmbH | 2395 |
5 |
| Oryzon Genomics S.A. | 103 |
5 |
| The General Hospital Corporation | 4840 |
4 |
| Northwestern University | 3530 |
4 |
| Cedars-Sinai Medical Center | 1189 |
4 |
| Denali Therapeutics Inc. | 261 |
4 |
| Romark Laboratories L.C. | 46 |
4 |
| Taisho Pharmaceutical Co., Ltd. | 855 |
4 |
| Qingdao Kingagroot Chemical Compound Co., Ltd. | 205 |
4 |
| Novartis AG | 10338 |
3 |
| AstraZeneca AB | 2830 |
3 |
| AstraZeneca UK Limited | 543 |
3 |
| Other owners | 155 |